Riskpilot← Back to searchSign inGet full accessAK Medicinkonsult AB
ABActiveOrg 5591118400Kullavägen 14General medical practice activities · NACE 8621Est. 20171-4 employees
Revenue 2025
SEK 580K
-48% vs 2024
EBITDA margin
20.0%
-83% vs 2024
Equity ratio
59.2%
Financial strength
Net profit 2025
SEK 132K
-69% vs 2024
| Revenue | SEK 580K | -48% |
| EBITDA | SEK 116K | -83% |
| Net profit | SEK 132K | -69% |
| Total assets | SEK 1,4M | -19% |
| Equity | SEK 804K | -10% |
| Employees | — | — |
Legal name
AK Medicinkonsult AB
Org number
5591118400
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
10 maj 2017
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva medicinsk konsultation, utbildning, personaluthyrning samt därmed förenlig verksamhet.
Address
Kullavägen 14
Email
ibrahim_aghil@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 639 | 636 | 781 | 1 110 | 580 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 523 | 451 | 489 | 697 | 116 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 523 | 451 | 489 | 697 | 116 |
| Net financials | — | −2 | 2 | 23 | 13 |
| Profit before tax | 393 | 348 | 492 | 539 | 168 |
| Tax | −81 | −72 | −102 | −112 | −36 |
| Net profit | 312 | 276 | 390 | 427 | 132 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 719 | 904 | 1 180 | 1 673 | 1 357 |
| Equity | 379 | 475 | 665 | 892 | 804 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 170 | 159 | 245 | 330 | 142 |
| Total debt | 170 | 159 | 245 | 330 | 142 |
EBITDA margin
20.0%
This company
15.8%
Market median
+27% vs market
20212025
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
20212025
Return on equity
16.4%
This company
18.4%
Market median
+11% vs market
20212025
Net profit margin
22.8%
This company
8.1%
Market median
+181% vs market
20212025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20212025
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2023 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AK Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aghil Ibrahim | Board of Directors | 0 companies |
| Ida Elisabeth Wendel | Deputy Board Member | 0 companies |
| Heidar Ibrahim | Deputy Board Member | 0 companies |